Disclaimer
This patient case series has been developed with the assistance of Professor Marc de Smet (Department of Ophthalmology, University of Leiden, The Netherlands; New York Eye & Ear Infirmary, Mount Sinai, New York, USA; MicroInvasive Ocular Surgery Center, Lausanne, Switzerland). This program was supported by AbbVie.
The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that some products may not be approved or commercially available in your country/market. Furthermore, products may have different product labeling according to geographical location. For instance, in Europe, full prescribing information is available from the European Medicines Agency (ema.europa.eu), and in the United States, from the US Food and Drug Administration (fda.gov).
AbbVie does not promote or condone the use of any medication or procedure for an off-label use.
This educational content has been approved by the sponsor for the following countries: Bahrain, China, Colombia, Germany, Kuwait, Oman, Qatar, Spain, United Arab Emirates.
All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for registered healthcare professionals. To proceed, please confirm that you are a registered healthcare professional.
Modules
A 57-year-old woman with diabetic retinopathy and DME;
A 55-year-old man with DME and fluctuating response to anti-VEGF monotherapy;
A 71-year-old woman with diabetes presenting with visual deterioration after cataract surgery.
